Redpoint Investment Management’s Edwards Lifesciences EW Stock Holding History

Redpoint Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.08M	Sell	13,096 -2,839	-18%	-$273K	0.16%	158
2022 Q2	$1.51M	Hold	15,935	–	–	0.18%	140
2022 Q1	$1.88M	Sell	15,935 -304	-2%	-$34.1K	0.19%	126
2021 Q4	$2.1M	Sell	16,239 -215	-1%	-$25.1K	0.17%	144
2021 Q3	$1.86M	Sell	16,454 -88	-0.5%	-$10K	0.16%	156
2021 Q2	$1.71M	Sell	16,542 -433	-3%	-$40.8K	0.14%	178
2021 Q1	$1.42M	Hold	16,975	–	–	0.12%	206
2020 Q4	$1.55M	Sell	16,975 -337	-2%	-$28K	0.16%	159
2020 Q3	$1.38M	Sell	17,312 -23,677	-58%	-$1.85M	0.15%	162
2020 Q2	$2.83M	Sell	40,989 -2,799	-6%	-$199K	0.16%	160
2020 Q1	$2.75M	Sell	43,788 -582	-1%	-$42K	0.17%	148
2019 Q4	$3.45M	Sell	44,370 -1,029	-2%	-$80.3K	0.17%	154
2019 Q3	$3.33M	Sell	45,399 -1,332	-3%	-$93.6K	0.18%	147
2019 Q2	$2.88M	Hold	46,731	–	–	0.15%	169
2019 Q1	$2.98M	Hold	46,731	–	–	0.15%	175
2018 Q4	$2.39M	Hold	46,731	–	–	0.14%	189
2018 Q3	$2.71M	Hold	46,731	–	–	0.14%	196
2018 Q2	$2.27M	Hold	46,731	–	–	0.12%	217
2018 Q1	$2.17M	Hold	46,731	–	–	0.12%	231
2017 Q4	$1.76M	Buy	+46,731	New	+$1.72M	0.1%	264

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redpoint Investment Management's EW Position: Q3 2022 in Review

Redpoint Investment Management reduced its Edwards Lifesciences (EW) stake by 18% in Q3 2022, selling an estimated $273K and leaving 13,096 shares worth $1.08M. The position accounts for 0.16% of the portfolio, ranked #158.

Redpoint Investment Management first reported a position in EW in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.45M in Q4 2019. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Redpoint Investment Management held 13,096 shares of Edwards Lifesciences worth $1.08M as of Q3 2022.
Redpoint Investment Management sold 2,839 Edwards Lifesciences shares in Q3 2022, an estimated $273K.
Edwards Lifesciences made up 0.16% of Redpoint Investment Management's portfolio in Q3 2022, its #158 holding.
Redpoint Investment Management first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 20 quarters since.
Redpoint Investment Management's Edwards Lifesciences position peaked at $3.45M in Q4 2019.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.